Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil to Prevent Coughing at Emergence
NCT03783676Phase 4Unknown
- Sponsor
- University of Vermont Medical Center
- Start
- Feb 2019
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of remifentanil in cough, sponsored by University of Vermont Medical Center. Status: unknown.
02
Drugs
remifentanil
03
Conditions
cough
Beyond the preview
Go deeper on NCT03783676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03783676.